Medine.co.uk

Dunlop'S 40 Cb Solution For Injection

Revised: June 2010

ATCVet code amended

SUMMARY OF PRODUCT CHARACTERISTICS


1. Name of the veterinary medicinal product


Dunlop’s 40CB Solution for Injection


2. Qualitative and quantitative composition


Active Substance:

40% w/v Calcium Borogluconate


Each 400ml contains:-

11.88g Calcium provided by Calcium Gluconate and Calcium Borogluconate.

Contains 6.5% w/v Boric Acid


Excipients:


For a full list of excipients, see section 6.1


3. Pharmaceutical form


Solution for injection

A clear, pale yellow liquid


4. Clinical Particulars


4.1 Target species


Cattle


4.2 Indications for use, specifying the target species


For the treatment of hypocalcaemia


4.3 Contra-indications


None


4.4 Special Warnings for each target species


None


4.5 Special precautions for use


i. Special precautions for use in animals


The solution should be warmed to body temperature before administration. Intravenous injections should be given slowly. Observe aseptic precautions.

Massage gently sites of subcutaneous administration.


ii. Special precautions to be taken by the person administering the veterinary medicinal product to animals


Care should be taken to avoid accidental self-injection: may cause irritation at site of injection.


4.6 Adverse reactions (frequency and seriousness)


Provided the recommendations are followed carefully, undesirable effects should not occur.


4.7 Use during pregnancy, lactation or lay


Dunlop’s 40CB can be safely administered to pregnant and lactating animals.


4.8 Interaction with other medicinal products and other forms of interaction


No known interactions.


4.9 Amounts to be administered and administration route


Administer by subcutaneous or slow intravenous injection at the following rate:


Cattle : 150 - 500 ml


Overdose (symptoms, emergency procedures, antidotes), if necessary


Not applicable.


Withdrawal period


Meat: Zero days

Milk: Zero hours


5. pharmacological properties


Pharmacotherapeutic group: Mineral supplements, Calcium


ATC Vet Code: QA12AA


Pharmacodynamic properties


Milk fever which is characterised by hypocalcaemia is caused by an acute drop in the level of ionised calcium. Administration of calcium borogluconate by subcutaneous or slow intravenous injection replenishes plasma calcium levels and reverses the hypocalcaemia.


6. Pharmaceutical particulars


6.1 List of excipients


Boric Acid (for pH adjustment)

Sodium Bicarbonate (for pH adjustment)

Water for Injections


Incompatibilities


None known


Shelf life


Shelf life of the veterinary medicinal product as packaged for sale: 3 years


Special precautions for storage


Do not store above 25ºC. Protect from light.

This product does not contain an antimicrobial preservative.

The product is intended for single use only. Any product remaining in the bottle after withdrawal of the first dose should be discarded.


Nature and composition of immediate packaging


400 ml Amber Type III glass vials sealed with black rubber wads and aluminium screw caps, or 400 ml white polypropylene containers sealed with grey bromobutyl bungs and aluminium caps.


Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products


Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.


7. MARKETING AUTHORISATION HOLDER


Norbrook Laboratories Limited

Station Works

Newry

Co. Down, BT35 6JP

Northern Ireland

8. MARKETING AUTHORISATION NUMBER(S)


Vm: 02000/4166


9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION


Date of first authorisation – 19th March 1996


10. DATE OF REVISION OF THE TEXT


June 2010


Page 4 of 4